Literature DB >> 9015319

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states.

R Levy1, L N Hazrati, M T Herrero, M Vila, O K Hassani, M Mouroux, M Ruberg, H Asensi, Y Agid, J Féger, J A Obeso, A Parent, E C Hirsch.   

Abstract

In the late 1980s, a functional and anatomical model of basal ganglia organization was proposed in order to explain the clinical syndrome of Parkinson's disease. According to this model, the pathological overactivity observed in the subthalamic nucleus and the output station of the basal ganglia plays a crucial role in the pathophysiology of the motor signs of Parkinson's disease. The hyperactivity of subthalamic neurons in Parkinsonism is viewed as a direct consequence of a pathological hypoactivity of the external segment of the pallidum. This article reviews recent data from different experimental approaches that challenge the established model of basal ganglia organization by reinterpreting the functional interaction between the external segment of the pallidum and the subthalamic nucleus in both the normal and pathological state. Indeed, recent neurobiochemical studies have rather unexpectedly shown that the GABAergic and metabolic activities of the external pallidum are not decreased in human and non-human primates with Parkinsonism. This absence of any decrease in activity might be explained by the functionally antagonistic influences of the striatal and subthalamic afferences within the external pallidum, as suggested by several anatomical studies. In addition, there are clues from electrophysiological studies to suggest that the hyperactivity found in the subthalamic neurons in Parkinsonism may not depend solely on the level of activity in the external pallidum. In such a framework, the hyperactivity of the subthalamic neurons would have to be explained, at least in part, by other sources of excitation or disinhibition. However, any explanation for the origin of the subthalamic overactivity in Parkinsonism remains speculative.

Entities:  

Mesh:

Year:  1997        PMID: 9015319     DOI: 10.1016/s0306-4522(96)00409-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  26 in total

1.  Activity patterns in a model for the subthalamopallidal network of the basal ganglia.

Authors:  D Terman; J E Rubin; A C Yew; C J Wilson
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

2.  Inducible ablation of dopamine D2 receptors in adult mice impairs locomotion, motor skill learning and leads to severe parkinsonism.

Authors:  E P Bello; R Casas-Cordero; G L Galiñanes; E Casey; M A Belluscio; V Rodríguez; D Noaín; M G Murer; M Rubinstein
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

3.  Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.

Authors:  Jordi Bové; Jordi Serrats; Guadalupe Mengod; Roser Cortés; Eduardo Tolosa; Concepció Marin
Journal:  Exp Brain Res       Date:  2005-06-21       Impact factor: 1.972

4.  Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode.

Authors:  C Beurrier; P Congar; B Bioulac; C Hammond
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

5.  Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease.

Authors:  N Nakao; M Ogura; K Nakai; T Itakura
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

6.  Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.

Authors:  R E Ryan; S A Ross; J Drago; R E Loiacono
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

7.  Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat.

Authors:  Nicholas MacInnes; Marcus J Messenger; Susan Duty
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

8.  Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging.

Authors:  Wei Zhang; Sheng-Gan Sun; Yu-Hong Jiang; Xian Qiao; Xin Sun; Yan Wu
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

9.  Dissociable effects of dopamine on neuronal firing rate and synchrony in the dorsal striatum.

Authors:  John M Burkhardt; Xin Jin; Rui M Costa
Journal:  Front Integr Neurosci       Date:  2009-10-30

Review 10.  Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.

Authors:  Dawn M Eagle; Christelle Baunez
Journal:  Neurosci Biobehav Rev       Date:  2009-07-15       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.